TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Business

    Industry Focus

    Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

    Advertise
    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Healthcare: Could A Reckoning at Rite Aid Spark an Amazon Acquisition? Jul 05, 2017
    Show notes

    After Walgreens' abandoned plans to buy it lock-stock-and-barrel, Rite Aid shares are crashing. Does this give Amazon.com the moment it's been waiting for to disrupt the prescription drug market?

    Thanks to Slack for supporting Motley Fool. Learn more at slack.com.


    Financials: Should Teenagers Get a Job? Jul 03, 2017
    Show notes

    There's no one, right answer, but getting a job while in school can help teach a lot of important things. Tune in to find out what Motley Fool contributors Dan Kline and Gaby Lapera think you ought to know.


    Tech: Can Pandora Catch Up? Jun 30, 2017
    Show notes

    In the past month, Pandora has sold off Ticketfly, announced a large investment stake from Sirius, and had its CEO step down. What should investors make of the shake-up? Plus we check in on Apple Music and Tesla's puzzling streaming music ambitions.


    Energy: Why Has the Entire Solar Sector Rallied Over the Past 2 Weeks? Jun 29, 2017
    Show notes

    Solar stocks are finaly rallying after a year of malaise, is this the long-rumored revound?


    Healthcare: The CBO Trips Up Trumpcare, Plus A Biotech “Spiffy-pop” Jun 28, 2017
    Show notes

    The Congressional Budget Office announces a discouraging outlook for Trumpcare. And Portola Pharmaceuticals’ shares increase more in one day than they cost last November.


    CG: 2 Best in Class Brick-and-Mortar Companies Jun 27, 2017
    Show notes

    After spending several months covering casualties, headwinds, and consolidation in the retail sector, we turn our attention to two companies that have thrived in the era of e-commerce. Ulta Beauty and TJX Companies are growing thanks to their physical store footprints, not in spite of them.


    Financials: Credit Ratings Agencies -- Companies that Rule the Financial World Jun 26, 2017
    Show notes

    Credit ratings agencies (CRAs) have the power to move markets, and decide the fortunes of publicly-traded companies around the world.


    Tech: The Amazon of Latin America Jun 23, 2017
    Show notes

    What doesn't MercadoLibre do? Today we talk about the Amazon/eBay/Craigslist/PayPal of Latin America, what's been fueling its impressive growth, and some of the things investors need to keep in mind if they're considering buying in.

    Thanks to Thumbtack for supporting Motley Fool (thumbtack.com).


    Energy: Planes, Trains, and Automobiles Jun 22, 2017
    Show notes

    There’s lots of ways to move goods and people in today’s economy, but which option is the most economical?


    Healthcare: How’s It Going to Be for AbbVie, Regeneron, Clovis, and More Jun 21, 2017
    Show notes

    AbbVie is developing new drugs to sidestep expiring patents on its best-seller, and a new FDA approval could be on deck at Clovis Oncology. Also, how Novartis plans to shake-up a multibillion dollar indication.


    Previous 1 112 113 114 115 116 205 Next

    Related Podcasts

    How I Built This with Guy Raz

    1

    How I Built This with Guy Raz Business
    Planet Money

    2

    Planet Money Business
    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters

    3

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters Business
    BiggerPockets Real Estate Podcast

    4

    BiggerPockets Real Estate Podcast Business
    The Smart Passive Income Online Business and Blogging Podcast

    5

    The Smart Passive Income Online Business and Blogging Podcast Business
    Bad With Money With Gabe Dunn

    6

    Bad With Money With Gabe Dunn Business
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights